GeroNova’s Stable, Low-Polymeric R-Lipoic Acid (as Na-RALA) powder encapsulated and supplied under manufacturer's labeling. Finally, authentic product direct from the supplier. No more worries over authenticity and potency of bulk powders from unknown suppliers.
60 x 300mg vegcaps. **PLEASE be aware and a careful shopper, this product is a full 300 mg active R-lipoic acid, not 210mg active RLA as some competitor products.** When comparing "apples to apples" cost per active mg per capsule, our 300mg is very cost competitive.
This material is the stable salt form (Na-RALA) of R-Lipoic Acid. Researchers believe that R-lipoic acid may be up to 8 times more active than Alpha-Lipoic Acid.
Unstabilized RLA can contain harmful heavy metals and residual solvents that are very difficult to remove. Geronova's processing removes all traces of residual solvents from the raw material.
Na-RALA is much more stable than RLA even at elevated temperatures. Heated to over 150° C for 6 hours there is no loss of activity, and polymer formation was undetectable. Pure RLA would instantaneously polymerize under these conditions.
This R-Lipoic Acid requires no refrigeration and does not polymerize, whereas unstabilized RLA polymerizes at temperatures slightly above ambient. The polymerization of RLA is accelerated by light, heat and moisture.
This form of r-lipoic acid (Na-RALA) does NOT offer the natural sustained release action of the MCT transported, liquicap, GeroNova products (R-PLUS, R-Plus CoQ10, Mito-GOLD).
Supplement Facts:
Serving Size: 1 Capsule.
Servings per container: 60
R-Lipoic Acid 300mg *
[derived from 435 mg Sodium-R-Lipoic Acid]
*Daily value not established
Other Ingredients:
Sodium bicarbonate (12%), magnesium stearate, vegetarian capsule.
Directions: Take 2-4 capsules daily, or as recommended by your health care provider, with or without meals.
K-RALA® requires no refrigeration and does not polymerize, whereas RLA polymerizes at temperatures slightly above ambient. The polymerization of RLA is accelerated by light, heat and moisture.
BIOAVAILABILITY refers to the amount (or percent of dose) of RLA that reaches the systemic blood circulation and is therefore available for use by the cells. Bioavailability is dependent upon absorption. In pharmacology, the absolute bioavailability of RLA measures the availability of RLA in the systemic circulation. This is determined by obtaining a blood plasma concentration over time, referred to as the AUC (area under the curve). Relative bioavailability compares the bioavailability of one product to another. In a preliminary human clinical trial, the AUC for GeroNova's Bio-Enhanced lipoic acid was 50 times higher than that of unstabilized RLA.
Related Items
Relentless Improvement LLC Products